{"nct_id":"NCT04908189","title":"A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2021-07-15","start_date_type":"ACTUAL","primary_completion_date":"2024-02-06","primary_completion_date_type":"ACTUAL","completion_date":"2026-11-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}